Name | Number of supported studies | Average coverage | |
---|---|---|---|
glutamatergic neuron | 9 studies | 51% ± 19% | |
oligodendrocyte precursor cell | 9 studies | 33% ± 15% | |
GABAergic neuron | 8 studies | 52% ± 20% | |
amacrine cell | 8 studies | 44% ± 26% | |
interneuron | 7 studies | 57% ± 17% | |
neuron | 7 studies | 40% ± 18% | |
retina horizontal cell | 5 studies | 34% ± 15% | |
GABAergic amacrine cell | 4 studies | 43% ± 14% | |
glycinergic amacrine cell | 4 studies | 30% ± 10% | |
GABAergic interneuron | 3 studies | 41% ± 8% | |
granule cell | 3 studies | 30% ± 1% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 9 studies | 39% ± 19% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 0% | 0 | 0 / 0 | 96% | 167.08 | 675 / 705 |
adrenal gland | 0% | 0 | 0 / 0 | 67% | 255.75 | 154 / 230 |
pancreas | 0% | 0 | 0 / 0 | 29% | 3.26 | 52 / 178 |
breast | 0% | 0 | 0 / 0 | 8% | 5.65 | 84 / 1118 |
stomach | 0% | 0 | 0 / 0 | 4% | 0.83 | 12 / 286 |
eye | 0% | 0 | 0 / 0 | 4% | 0.92 | 3 / 80 |
intestine | 0% | 0 | 0 / 0 | 3% | 0.14 | 15 / 527 |
lung | 0% | 0 | 0 / 0 | 2% | 1.44 | 26 / 1155 |
bladder | 0% | 0 | 0 / 0 | 2% | 0.46 | 10 / 504 |
uterus | 0% | 0 | 0 / 0 | 2% | 0.14 | 9 / 459 |
prostate | 0% | 0 | 0 / 0 | 2% | 0.11 | 9 / 502 |
skin | 0% | 0 | 0 / 0 | 1% | 0.12 | 4 / 472 |
thymus | 0% | 0 | 0 / 0 | 1% | 0.04 | 4 / 605 |
esophagus | 0% | 0 | 0 / 0 | 1% | 0.19 | 1 / 183 |
liver | 0% | 0 | 0 / 0 | 0% | 0.04 | 2 / 406 |
kidney | 0% | 0 | 0 / 0 | 0% | 0.02 | 3 / 901 |
ovary | 0% | 0 | 0 / 0 | 0% | 0.02 | 1 / 430 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
adipose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
blood vessel | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
heart | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
muscle | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spleen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0048268 | Biological process | clathrin coat assembly |
GO_0016197 | Biological process | endosomal transport |
GO_0007212 | Biological process | G protein-coupled dopamine receptor signaling pathway |
GO_0032588 | Cellular component | trans-Golgi network membrane |
GO_1990674 | Cellular component | Golgi cis cisterna membrane |
GO_0031901 | Cellular component | early endosome membrane |
GO_0043202 | Cellular component | lysosomal lumen |
GO_0005768 | Cellular component | endosome |
GO_0030425 | Cellular component | dendrite |
GO_0005770 | Cellular component | late endosome |
GO_0005794 | Cellular component | Golgi apparatus |
GO_0032585 | Cellular component | multivesicular body membrane |
GO_0030659 | Cellular component | cytoplasmic vesicle membrane |
GO_0016020 | Cellular component | membrane |
GO_0005769 | Cellular component | early endosome |
GO_0032051 | Molecular function | clathrin light chain binding |
GO_0005515 | Molecular function | protein binding |
Gene name | NSG2 |
Protein name | HMP19 protein, isoform CRA_c (Neuronal vesicle trafficking associated 2) Neuronal vesicle trafficking associated 2 Neuronal vesicle trafficking-associated protein 2 (Neuron-specific protein family member 2) (Protein p19) (Hmp19) |
Synonyms | HMP19 hCG_41130 CALY3 |
Description | |
Accessions | ENST00000521585.5 E5RGE8 G3XAM5 ENST00000519867.5 ENST00000517587.5 Q9Y328 ENST00000519717.1 E5RH73 E5RHS6 ENST00000303177.8 ENST00000521278.5 |